Skip to content
My WebMD Sign In, Sign Up

Hepatitis Health Center

Font Size

Hepatitis C Infection May Have 'Silver Lining' for Transplant Patients

Infected people who need new organ might have less need for immune-suppressing drugs, study finds


Dr. Thomas Schiano, medical director of liver transplant for Mount Sinai Health System, said the very small study "does give us some confidence as to us to be able to wean people off of immunosuppression."

But he added that new breakthroughs in hepatitis C treatment may make the point moot, anyway.

"Effective new medicines are probably going to make this not as pertinent," Schiano said. "If we are able to get rid of the hepatitis C in a majority of patients, that will provide further confidence to transplant surgeons to get patients off of immunosuppression."

A second, related study in the same journal issue found that laboratory-engineered immune cells can help treat serious viral infections that threaten to cause rejection in organ transplant patients.

A team led by Dr. Ann Leen, of Texas Children's Hospital in Houston, said they've developed a technique to rapidly produce immune cells capable of fighting of up to five different viruses known to cause organ rejection, including Epstein-Barr virus and herpes virus.

The engineered cells eliminated nearly all viruses from a small group of patients, the researchers reported.

"These viruses are a big source of graft [new organ] failure. This is something clearly worth exploring further," Schiano said. "The cost associated with this would be mitigated by all the money we spend to protect against infection."


Today on WebMD

Hepatitus C virus
young couple
Hepatitis Basics
Hepatitis Prevent 10
Hepatitis C Treatment
Syringes and graph illustration
liver illustration
passport, pills and vaccine
Scientist looking in microscope
Fatty Liver Disease
Digestive Diseases Liver Transplantation
Picture Of The Liver
Image Collection